Approaching China s Pharmaceutical Market 2015: A Fundamental Guide to Clinical Drug Development (Hardback)
6 Angebote vergleichen
| Preise | 2015 | 2017 | 2023 |
|---|---|---|---|
| Schnitt | € 187,82 | € 177,44 | € 160,49 |
| Nachfrage |
1
Approaching China's Pharmaceutical Market
~EN HC NWISBN: 9783319155753 bzw. 331915575X, vermutlich in Englisch, Springer Nature, gebundenes Buch, neu.
Lieferung aus: Deutschland, Lagernd, zzgl. Versandkosten.
This authoritative volume examines the major laws, regulations and guidelines related to pharmaceutical product development in China. With a focus on patent, clinical and registration strategies, the book helps Western companies introduce their clinical drugs to the Chinese market, determine a strategic path and bridge the gap for regulatory and legal differences between China and the Western world. For a better understanding of the drug registration process, it explores the differences between the China Food and Drug Administration (CFDA)—including its regulations and registration procedures—and those of the Western world. The volume discusses disparities between China's application requirements compared to Western standards to make it easier for companies to prepare their application packages. It also provides detailed commentary on CFDA guidelines in reference to clinical trial (IND) and market application (NDA) requirements. Overall, this book offers guidance for Western companies aspiring to expand into China’s pharmaceutical market in hopes that they may gain a fundamental understanding of its rules and complexities in order to ensure a smooth transition and prevent future issues. Hard cover.
This authoritative volume examines the major laws, regulations and guidelines related to pharmaceutical product development in China. With a focus on patent, clinical and registration strategies, the book helps Western companies introduce their clinical drugs to the Chinese market, determine a strategic path and bridge the gap for regulatory and legal differences between China and the Western world. For a better understanding of the drug registration process, it explores the differences between the China Food and Drug Administration (CFDA)—including its regulations and registration procedures—and those of the Western world. The volume discusses disparities between China's application requirements compared to Western standards to make it easier for companies to prepare their application packages. It also provides detailed commentary on CFDA guidelines in reference to clinical trial (IND) and market application (NDA) requirements. Overall, this book offers guidance for Western companies aspiring to expand into China’s pharmaceutical market in hopes that they may gain a fundamental understanding of its rules and complexities in order to ensure a smooth transition and prevent future issues. Hard cover.
2
Approaching China's Pharmaceutical Market, A Fundamental Guide to Clinical Drug Development: 2015 (2015)
DE HC NWISBN: 9783319155753 bzw. 331915575X, in Deutsch, Springer International Publishing AG, gebundenes Buch, neu.
Lieferung aus: Niederlande, 2-3 werkdagen.
bol.com.
This authoritative volume examines the major laws, regulations and guidelines related to pharmaceutical product development in China. With a focus on patent, clinical and registration strategies, the book helps Western companies introduce their clinical drugs to the Chinese market, determine a strategic path and bridge the gap for regulatory and legal differences between China and the Western world. For a better understanding of the drug registration process, it explores the differences between ... This authoritative volume examines the major laws, regulations and guidelines related to pharmaceutical product development in China. With a focus on patent, clinical and registration strategies, the book helps Western companies introduce their clinical drugs to the Chinese market, determine a strategic path and bridge the gap for regulatory and legal differences between China and the Western world. For a better understanding of the drug registration process, it explores the differences between the China Food and Drug Administration (CFDA)-including its regulations and registration procedures-and those of the Western world. The volume discusses disparities between China's application requirements compared to Western standards to make it easier for companies to prepare their application packages. It also provides detailed commentary on CFDA guidelines in reference to clinical trial (IND) and market application (NDA) requirements. Overall, this book offers guidance for Western companies aspiring to expand into China's pharmaceutical market in hopes that they may gain a fundamental understanding of its rules and complexities in order to ensure a smooth transition and prevent future issues.Taal: Engels;Afmetingen: 37x235x155 mm;Gewicht: 1,15 kg;Verschijningsdatum: juli 2015;Druk: 1;ISBN10: 331915575X;ISBN13: 9783319155753; Engelstalig | Hardcover | 2015.
bol.com.
This authoritative volume examines the major laws, regulations and guidelines related to pharmaceutical product development in China. With a focus on patent, clinical and registration strategies, the book helps Western companies introduce their clinical drugs to the Chinese market, determine a strategic path and bridge the gap for regulatory and legal differences between China and the Western world. For a better understanding of the drug registration process, it explores the differences between ... This authoritative volume examines the major laws, regulations and guidelines related to pharmaceutical product development in China. With a focus on patent, clinical and registration strategies, the book helps Western companies introduce their clinical drugs to the Chinese market, determine a strategic path and bridge the gap for regulatory and legal differences between China and the Western world. For a better understanding of the drug registration process, it explores the differences between the China Food and Drug Administration (CFDA)-including its regulations and registration procedures-and those of the Western world. The volume discusses disparities between China's application requirements compared to Western standards to make it easier for companies to prepare their application packages. It also provides detailed commentary on CFDA guidelines in reference to clinical trial (IND) and market application (NDA) requirements. Overall, this book offers guidance for Western companies aspiring to expand into China's pharmaceutical market in hopes that they may gain a fundamental understanding of its rules and complexities in order to ensure a smooth transition and prevent future issues.Taal: Engels;Afmetingen: 37x235x155 mm;Gewicht: 1,15 kg;Verschijningsdatum: juli 2015;Druk: 1;ISBN10: 331915575X;ISBN13: 9783319155753; Engelstalig | Hardcover | 2015.
3
Symbolbild
Approaching China's Pharmaceutical Market: A Fundamental Guide to Clinical Drug Development
DE HC NWISBN: 9783319155753 bzw. 331915575X, in Deutsch, Springer, gebundenes Buch, neu.
Lieferung aus: Kanada, Плус испорука.
Von Händler/Antiquariat, Russell Books Ltd.
Springer. Hardcover. 331915575X Special order direct from the distributor . New.
Von Händler/Antiquariat, Russell Books Ltd.
Springer. Hardcover. 331915575X Special order direct from the distributor . New.
4
Approaching China's Pharmaceutical Market (2015)
DE HC NWISBN: 9783319155753 bzw. 331915575X, in Deutsch, Springer International Publishing, gebundenes Buch, neu.
Lieferung aus: Deutschland, Плус испорука, sofort lieferbar.
A Fundamental Guide to Clinical Drug Development, Buch, Hardcover, 1st ed. 2015.
A Fundamental Guide to Clinical Drug Development, Buch, Hardcover, 1st ed. 2015.
5
Approaching China's Pharmaceutical Market : A Guide to Drug Development and.
DE NWISBN: 9783319155753 bzw. 331915575X, in Deutsch, neu.
Lieferung aus: Vereinigte Staaten von Amerika, Врста испоруке: Free, Достава: Vereinigte Staaten von Amerika, Понуда локације: USA, Бесплатан транспорт.
Von Händler/Antiquariat, barnesandnobleinc - Barnes and Noble Store.
Sold directly by Barnes & Noble, Фиксна цена.
Von Händler/Antiquariat, barnesandnobleinc - Barnes and Noble Store.
Sold directly by Barnes & Noble, Фиксна цена.
6
Approaching China's Pharmaceutical Market: A Fundamental Guide to Clinical Drug
DE NWISBN: 9783319155753 bzw. 331915575X, in Deutsch, neu.
Lieferung aus: Vereinigtes Königreich Großbritannien und Nordirland, Врста испоруке: Flat, Достава: Широм света, Понуда локације: United Kingdom.
Von Händler/Antiquariat, roxy*media*uk - uk_media_superstore.
Фиксна цена.
Von Händler/Antiquariat, roxy*media*uk - uk_media_superstore.
Фиксна цена.
Lade…